重大事件
即時報告
8-K
2026-06-04
目前暫無具體的財政季度或年度金額可供參考，建議關注公司後續的正式公告或季度報告以獲取更詳細的財務資訊。
AI 繁中摘要
FATE Therapeutics（代碼：FATE）於2026年6月4日向美國SEC提交了一份8-K表格，報告一項其他事件（Item 8.01）及相關財務報表與附件（Item 9.01）。該申報文件主要包含一份附件EX-99.1（通常為新聞稿或投資者簡報），但文件中未列出具體財務數字或業績數據。📄
由於8-K僅用於披露重大事件，此次申報可能涉及公司業務或管治方面的最新動向（例如臨床試驗進展、合作協議或管理層變動等）。投資者應仔細查閱EX-99.1附件及完整申報內容，以了解事件細節及其對公司前景的潛在影響。🔍
目前暫無具體的財政季度或年度金額可供參考，建議關注公司後續的正式公告或季度報告以獲取更詳細的財務資訊。
展開英文正文
EDGAR Filing Documents for 0001193125-26-257558 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-257558 Filing Date 2026-06-04 Accepted 2026-06-04 16:37:03 Documents 44 Period of Report 2026-06-04 Items Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K d83385d8k.htm iXBRL 8-K 25596 2 EX-99.1 d83385dex991.htm EX-99.1 66898 6 GRAPHIC g83385page004.jpg GRAPHIC 294038 7 GRAPHIC g83385page005.jpg GRAPHIC 485818 8 GRAPHIC g83385page006.jpg GRAPHIC 404144 9 GRAPHIC g83385page007.jpg GRAPHIC 350387 10 GRAPHIC g83385page008.jpg GRAPHIC 334486 11 GRAPHIC g83385page009.jpg GRAPHIC 303051 12 GRAPHIC g83385page010.jpg GRAPHIC 298234 13 GRAPHIC g83385page011.jpg GRAPHIC 196968 14 GRAPHIC g83385page012.jpg GRAPHIC 320616 15 GRAPHIC g83385page013.jpg GRAPHIC 326226 16 GRAPHIC g83385page014.jpg GRAPHIC 331395 17 GRAPHIC g83385page015.jpg GRAPHIC 264379 18 GRAPHIC g83385page016.jpg GRAPHIC 366567 19 GRAPHIC g83385page017.jpg GRAPHIC 280483 20 GRAPHIC g83385page018.jpg GRAPHIC 284220 21 GRAPHIC g83385page019.jpg GRAPHIC 388259 22 GRAPHIC g83385page020.jpg GRAPHIC 382953 23 GRAPHIC g83385page021.jpg GRAPHIC 191142 24 GRAPHIC g83385page022.jpg GRAPHIC 320952 25 GRAPHIC g83385page023.jpg GRAPHIC 838827 26 GRAPHIC g83385page024.jpg GRAPHIC 320935 27 GRAPHIC g83385page025.jpg GRAPHIC 327224 28 GRAPHIC g83385page026.jpg GRAPHIC 398957 29 GRAPHIC g83385page027.jpg GRAPHIC 376154 30 GRAPHIC g83385page028.jpg GRAPHIC 362060 31 GRAPHIC g83385page029.jpg GRAPHIC 439705 32 GRAPHIC g83385page030.jpg GRAPHIC 289217 33 GRAPHIC g83385page031.jpg GRAPHIC 347287 34 GRAPHIC g83385page032.jpg GRAPHIC 188476 35 GRAPHIC g83385page033.jpg GRAPHIC 195823 36 GRAPHIC g83385page034.jpg GRAPHIC 446370 37 GRAPHIC g83385page035.jpg GRAPHIC 313663 Complete submission text file 0001193125-26-257558.txt 15332674 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA fate-20260604.xsd EX-101.SCH 3204 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20260604_lab.xml EX-101.LAB 17233 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20260604_pre.xml EX-101.PRE 10828 48 EXTRACTED XBRL INSTANCE DOCUMENT d83385d8k_htm.xml XML 3539 Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803 FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings) EIN.: 651311552 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 261065574 SIC: 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)